Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.6010
-0.0153 (-2.48%)
At close: Jun 2, 2026, 4:00 PM EDT
0.6500
+0.0490 (8.15%)
Pre-market: Jun 3, 2026, 6:31 AM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,571
Profits / Employee
-$1,361,417
Market Cap
14.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Lunai Bioworks | 29 |
| BioLineRx | 24 |
| Jasper Therapeutics | 22 |
| OSR Holdings | 22 |
| IN8bio | 17 |
| SeaStar Medical Holding | 17 |
| Cocrystal Pharma | 10 |
LEXX News
- 14 days ago - Lexaria Bioscience announces ethics approval for Human Pilot Study 7 - TheFly
- 14 days ago - Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 - Accesswire
- 26 days ago - Lexaria Bioscience Releases Second Episode of Investor Video Series - Accesswire
- 4 weeks ago - Lexaria Bioscience provides update on Human Pilot Study #7 - TheFly
- 4 weeks ago - Lexaria Updates Progress on Human Study #7 - Accesswire
- 4 weeks ago - Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications - TheNewswire
- 4 weeks ago - Lexaria Bioscience extends material transfer agreement with pharma company - TheFly
- 4 weeks ago - Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - TheNewswire